Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Brain : a journal of neurology·2026
Same author

Neuropathic pain in multiple sclerosis: discrepancies between DN4 screening and neurophysiological measures.

Multiple sclerosis and related disorders·2026
Same author

Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis Registry.

BMJ neurology open·2026
Same author

Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.

Frontiers in neuroscience·2026
Same author

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

The Lancet. Neurology·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
查看所有相关文章

相关实验视频

Updated: Jun 27, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

[多发性硬化症的治疗方法:更新]

Marjolaine Uginet1, Lucie Lefeuvre1, Julien Lerusse1

  • 1Unité de neuro-immunologie, Service de neurologie, Département des neurosciences cliniques, Hôpitaux universitaires de Genève et Faculté de médecine, 1211 Genève 4.

Revue medicale suisse
|April 26, 2024
PubMed
概括
此摘要是机器生成的。

多发性硬化症 (MS) 管理的近期进展包括高效的治疗方法,特别是抗CD20抗体,现在可用于渐进的形式. 了解它们的机制和风险,如机会性感染,对于有效的MS护理至关重要.

更多相关视频

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.3K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K

相关实验视频

Last Updated: Jun 27, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.3K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 多发性硬化症 (MS) 管理已经被新的,高效的疗法所改变.
  • 治疗干预越来越多地在早期开始,有时在临床诊断之前.

研究的目的:

  • 审查2024年可用的MS进展预防治疗的现状.
  • 突出反CD20抗体在MS治疗中的作用和考虑因素,包括渐进的形式.

主要方法:

  • 关于多发性硬化症近期治疗进展的文献综述.
  • 对治疗机制,疗效和安全概况的分析.

主要成果:

  • 多发性硬化症的治疗武器库现在包括强大的疾病修饰疗法.
  • 抗CD20抗体是治疗的基石,对渐进性多发性硬化症有越来越多的征兆.
  • 免疫抑制疗法需要对潜在风险进行仔细监测,例如机会性感染.

结论:

  • 多发性硬化症的治疗有了显著的进步,可以更好地控制疾病的进展.
  • 抗CD20疗法代表了一项重大的治疗进步,需要对其益处和风险有充分的了解.
  • 有信息的临床决策对于优化MS管理中的患者结果至关重要.